DEXTROSE; SODIUM CHLORIDE | A211190 | FRESENIUS KABI USA LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Fujian Shengdi Pharmaceutical Co., Ltd. FDA-2022-P-1739 Fujian Shengdi Pharmaceutical Co., Ltd. filed this citizen petition under 21 CFR §10.20 and §10.30 on July 28, 2022, requesting that the FDA designate the Dextrose 2.5% and Sodium Chloride 0.45% Injection in Plastic Container from FRESENIUS KABI USA LLC (application number A211190) as an additional | 505(q) | 2022-07-29 | Withdrawn | Fujian Shengdi Pharmaceutical Co. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.